Skip to main content

Erzofri extended-release

NDC 72526-107 · Shandong Luye Pharmaceutical Co., Ltd.

Generic namepaliperidone palmitate
Dosage formINJECTION
RouteINTRAMUSCULAR
Active ingredient(s)PALIPERIDONE PALMITATE
Strength117 mg/.75mL
Pharmacologic classAtypical Antipsychotic [EPC]
Marketing categoryNDA

Packages

72526-107-11 — 1 SYRINGE, GLASS in 1 KIT (72526-107-11) / .75 mL in 1 SYRINGE, GLASS

Billed under HCPCS

J2428 — Injection, paliperidone palmitate extended release (erzofri), 1 mg Medicare Part B payment limit (ASP + 6%): $15.87

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50458-560 — paliperidone palmitate, 50458-561 — paliperidone palmitate, 50458-562 — paliperidone palmitate, 50458-563 — paliperidone palmitate, 50458-564 — paliperidone palmitate, 50458-606 — paliperidone palmitate, 50458-607 — paliperidone palmitate, 50458-608 — paliperidone palmitate, 50458-609 — paliperidone palmitate, 50458-611 — paliperidone palmitate, 50458-612 — paliperidone palmitate, 72526-105 — paliperidone palmitate, 72526-106 — paliperidone palmitate, 72526-108 — paliperidone palmitate, 72526-109 — paliperidone palmitate, 72526-110 — paliperidone palmitate

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.